Explore 3 Stock Ideas & Industry Insights Download Free Report

mid-cap

Technical Analysis on One US-Listed Health Care Stock – TMDX

Feb 15, 2026 | Team Kalkine
Technical Analysis on One US-Listed Health Care Stock – TMDX
Image source: Shutterstock

  • TMDX:NASDAQ
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Company Overview: TransMedics Group, Inc. (NASDAQ: TMDX) is a commercial-stage medical technology company that is disrupting the organ transplant industry by replacing traditional "cold storage" with a system that mimics the human body's natural state. This Report covers the Price Action, Technical Indicators Analysis along with the Support Levels, Resistance Levels, and Recommendations on this stock.

Financial Performance & Guidance: TransMedics reported total revenue of $143.8 million in Q3 2025, representing approximately 32% year-over-year growth, driven by strong demand across its organ transplant segments. Net income rose sharply to $24.3 million compared with $4.2 million in Q3 2024, reflecting significant improvement in profitability. Diluted earnings per share came in at $0.66, exceeding the analyst consensus estimate of about $0.37 by roughly $0.29. Gross margin expanded to 59% from 56% in the prior-year quarter, supported by higher utilization and operational efficiencies, while operating expenses increased modestly to $61.3 million as the company continued investing in research and development and organizational expansion.

Performance was broad-based across all organ segments, with particularly strong growth in liver and heart revenue. The company ended the quarter with $466.2 million in cash and equivalents, reinforcing a solid liquidity position. Reflecting confidence in ongoing execution and demand trends, TransMedics raised its full-year 2025 revenue guidance to a range of approximately $595 million to $605 million.

TMDX’s Technical Analysis:

While undergoing a rally, TMDX's stock price is forming a symmetrical triangle pattern, indicating a positive bias. Additionally, price is approaching a support established by its previous trough, providing further support for the mentioned recommendation. Price is trading between its previous, which may potentially function as resistance and support levels for the stock, respectively. Crucial support for the stock is positioned at USD 119.00, while key resistance is placed at USD 156.00.

Daily Technical Chart – TMDX

Considering the stock’s current price levels forming a symmetrical triangle pattern during a rally, and momentum oscillator analysis, a “Speculative Buy” recommendation is given on the stock. The stock was analysed as per the closing price of USD 129.84 per share as on 13 February 2026, up by 1.03%.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: Investment decision should be made depending on an individual’s appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report.

Note 3: Related Risks: This report may be looked at from high-risk perspective and recommendations are provided are for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

The reference date for all price data, currency, technical indicators, support, and resistance levels is February 13, 2026. The reference data in this report has been partly sourced from REFINITIV.

Technical Indicators Defined:

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

The Green colour line reflects the 21-period moving average. SMA helps to identify existing price trends. If the prices are trading above the 21-period, prices are currently in a bullish trend (Vice – Versa).

The Blue colour line reflects the 50-period moving average. SMA helps to identify existing price trends. If the prices are trading above the 50-period, prices are currently in a bullish trend (Vice – Versa).

The Orange/ Yellow colour line represents the Trendline.

The Purple colour line in the chart’s lower segment reflects the Relative Strength Index (14-Period), which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status, while a reading of 30 or below suggests an oversold status.


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…